Byoung Joon Kim

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder

Ju‐Hong Min, Byoung Joon Kim, Kwang Ho Lee · Multiple Sclerosis Journal · 2011 · 282 citations

Extensive Brain Lesions, Ophthalmology, Scleroderma +13

Mutations in DDX58, which Encodes RIG-I, Cause Atypical Singleton-Merten Syndrome

Mi‐Ae Jang, Eun Kyoung Kim, Hesung Now et al. · The American Journal of Human Genetics · 2015 · 208 citations · Full text

Encodes Rig-i, Somatic Variant, Mendelian Disorder +7

The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders

So‐Young Huh, Ju‐Hong Min, Woojun Kim et al. · Multiple Sclerosis Journal · 2013 · 84 citations

Clinical predictors of steroid-induced exacerbation in myasthenia gravis

Jong Seok Bae, Seok Min Go, Byoung Joon Kim · Journal of Clinical Neuroscience · 2006 · 79 citations

Metabolic Syndrome, Dermatology, Glucocorticoid +5